John Poulos
Director/Board Member bei FARON PHARMACEUTICALS OY
Vermögen: 17 370 $ am 31.03.2024
Profil
Mr. John Poulos is an Independent Non-Executive Director at Faron Pharmaceuticals Oy and a President at GNK Advisors, Inc. He is on the Board of Directors at Memgen, Inc. and Faron Pharmaceuticals Oy.
Mr. Poulos was previously employed as a VP, Head-Business Development & Acquisitions by AbbVie Oy and a Head-Pharmaceutical Licensing & Acquisitions by Abbott Pharmaceutical, Inc. He received his undergraduate degree from Indiana University and an MBA from Indiana University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FARON PHARMACEUTICALS OY
0,01% | 27.10.2023 | 10 000 ( 0,01% ) | 17 370 $ | 31.03.2024 |
Aktive Positionen von John Poulos
| Unternehmen | Position | Beginn |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 16.05.2017 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Director/Board Member | 18.11.2020 |
| GNK Advisors, Inc. | President | 01.01.2017 |
Ehemalige bekannte Positionen von John Poulos
| Unternehmen | Position | Ende |
|---|---|---|
AbbVie Oy
 AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Corporate Officer/Principal | 01.01.2016 |
| Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von John Poulos
| Indiana University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FARON PHARMACEUTICALS OY | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
| Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Health Technology |
| GNK Advisors, Inc. |
